World Health Organisation (WHO) Evaluating Microdacyn For World Essential Medicines List
March 6 2017
The World Health Organisation (WHO) has accepted for review the first ever New Zealand based submission for a product entry on the Essential Medicines List.
The World Health Organisation (WHO) Essential Medicines List (EML) committee considers Microdacyn technology during April. Microdacyn is a super oxidised solution used to prevent and manage infection while clinically provides faster wound healing. The Essential Medicines List contains carefully selected medicines and medical devices to meet the needs of near 84% of the worlds population, those living in poor, lower or middle income countries.
The EML is also a guide for the funded availability of medicines and medical devices through governments and organisations such as UNICEF.
A successful listing would mean the poor, lower and middle countries would be able to access the same wound care and infection control product Microdacyn, which is currently used in Australia, Europe, New Zealand and the USA.
Background on the EML is here http://www.who.int/medici
For any queries please contact firstname.lastname@example.org.< Back to News